Event
18 Nov 2025
This event will be held at the Royal Society of Medicine, London, on 18 November 2025.
Hosted jointly by the Fleming Initiative (Imperial College London & Imperial College NHS Trust), the Ineos Oxford Institute for antimicrobial research (Oxford University) and GSK, this event will pay tribute to the pioneering work of Sir Alexander Fleming, who discovered penicillium mould in his laboratory at St Mary’s Hospital (now part of Imperial College London); and to Sir Ernst Chain and Lord Howard Florey, who isolated and purified it for clinical use in Oxford. Large scale production of penicillin was possible due to funding from the US government and the industrial capabilities of companies such as Glaxo (now GSK).
The event will bring together scientists, communicators, business leaders, and policymakers to explore new approaches across three central themes essential to tackling AMR: communication, science, and policy, with discussions focusing on:
What innovative approaches are being developed across science, policy and engagement?
What levers or ecosystem changes are needed to ensure these innovations have the impact we anticipate?
How can we position AMR as an anchor problem in society that enables us to drive a movement of change?
November 18th Agenda:
16:30-16:10 - Building upon a legacy of innovation
16:30-17:00 - "The ignorant man" - Sir Alexander Fleming: Creatively engaging society on AMR
17:00-17:10 - Uniting science, tech and talent to get ahead of AMR together
17:10-17:50 - "The adventurous human mind" - Sir Ernst Chain: The next frontiers in AMR
17:50-18:20 - "Politicians of the world are at last aware" - Lord Howard Florey: Keeping AMR in the political & financial consciousness
18:20-18:30 - A surgeon's perspective through time
18:30 - Closing address
Please note that this event is invite-only.